Pharmaceuticals, Biotechnology and Life Sciences
– First-quarter 2019 product revenues of $857 million, a 34% increase compared to $638 million in 2018- – First-quarter 2019…
Chinese registrational clinical trial for derazantinib to begin in 2H 2019 BURLINGTON, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ARQL&src=ctag” target=”_blank”gt;$ARQLlt;/agt; lt;a href=”https://twitter.com/hashtag/arql?src=hash” target=”_blank”gt;#arqllt;/agt;–ArQule, Inc.’s…
− In the United States, Company Completes Tenth Value-Based Agreement with Commercial Payers, and Achieves Confirmed Access to ONPATTRO for…
DUBLIN–(BUSINESS WIRE)–The “Cell Expansion Market by Product, Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer &…
DUBLIN–(BUSINESS WIRE)–The “Development of Combination Products: Critical Interactions” conference has been added to ResearchAndMarkets.com’s offering. Linking the technical requirements of…
DUBLIN–(BUSINESS WIRE)–The “Working Through Veterinary Drug Development in the EU and USA” conference has been added to ResearchAndMarkets.com’s offering. This…
-Opportunity to treat the underlying cause of CF earlier than ever before- -Safety data from Phase 3 ARRIVAL study support…
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia–(BUSINESS WIRE)–Date of conference call should read:…
Company to focus on benefits of CBD for non-addictive pain management and opioid, alcohol addiction recovery NEWPORT BEACH, Calif.–(BUSINESS WIRE)–lt;a…
DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The…